References
- Crowley K. Sleep and sleep disorders in older adults. Neuropsychol Rev 2011;21:41–53
- Sueblinvong T, Taechakraichana N, Phupong V. Prevalence of climacteric symptoms according to years after menopause. J Med Assoc Thai 2001;84:1681–91
- Mai E, Buysse DJ. Insomnia: prevalence, impact, pathogenesis, differential diagnosis, and evaluation. Sleep Med Clin 2008;3:167–74
- Huang KE, Baber R. Update in clinical recommendations for the use of tibolone in Asian women. Climacteric 2010;13:317–27
- Lauren SS, Buysse DJ, Dorsey C, et al. Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults. J Clin Sleep Med 2009;4:487–504
- Halbreich U, Kahn LS. Role of estrogen in the aetiology and treatment of mood disorders. CNS drug 2001;15:797–817
- Gass M, Manson J, Cosman F, et al. Position Statement the 2012 Hormone Therapy Position Statement of the North American Menopause Society. Menopause 2012;19:257–71
- Buysse DJ. Diagnosis and classification of insomnia disorders. In Szuba MP, Kloss JD, Dinges DF, eds. Insomnia: Principle and Management. Cambridge: University of Cambridge, 2003:7–9
- Polo-Kantola P, Erkkola R, Helenius H, et al. When does estrogen replacement therapy improve sleep quality? Am J Obstet Gynecol 1998;178:1002–9
- Gordon SF. Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapy. Am J Obtet Gynecol 1995;173:998–1004
- Bush A, Shen L, Kelly S, et al. Steady-state bioavailability of estradiol from two matrix transdermal delivery systems, Alora and Climara. Menopause 1998;5:107–12
- FDA News Release. FDA Update on Hormone Therapy for Post Menopausal Women [Internet]2004 (cited 2004 Feb 10) Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2004/ucm108243
- Saletu B. Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest. Climacteric 2003;6:37–45
- Claudo N, Brian J. Sleep disorders in women: Clinical evidence and treatment strategies. Psychiatr Clin N Am 2006;29: 1095–113
- Thomson J, Oswald I. Effect of oestrogen on the sleep, mood, and anxiety of menopausal women. Br Med J 1977;2:1317–19
- Wiklund I, Hammar M, Karlberg J, et al. Long term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women. Maturitas 1992;14:225–36
- Tait D, Debra L, Alex A, et al. Pathophysiology and treatment of hot flashes. Mayo Clin Prac 2002;77:1207–18
- Sarti CD, Chiantera A, Graziottin A, et al. Hormone therapy and sleep quality in women around menopause. Menopause 2005; 12:545–51
- Ohayon MM. Severe hot flashes are associated with chronic insomnia. Arch Intern Med 2006;166;1262–8
- Krystal AD, Edinger J, Wohlgemuth W, et al. Sleep in peri- menopausal and post-menopausal women. Sleep Med Rev 1998; 2:243–58
- Kenneth L, Kristen C, James D, et al. Actigraphy validation with insomnia. Sleep 2006;29:232–9
- Antonijevic IA, Stalla GK, Steiger A. Modulation of the sleep electroencephalogram by estrogen replacement in postmenopausal women. Am J Obstet Gynecol 2000;182:277–82
- Erlik Y, Tataryn IV, Meldrum DR, et al. Association of waking episodes with menopausal hot flushes. JAMA 1981;245:1741–4
- Morin CM, Belleville G, Bélanger L, et al. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment. Sleep 2011;34:601–8
- Jone MW. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 1991;14:540–5
- Ohayon MM, Carskadon MA, Guilleminault C, et al. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep 2004;27:1255–73